Announcement on Voluntary Disclosure of the Approval of Marketing Registration for Contezolid API from New Additional Manufacturer

About this update from Shanghai Micurx Pharmaceutical Co., Ltd. Class A

Announcement on Voluntary Disclosure of the Approval of Marketing Registration for Contezolid API from New Additional ManufacturerThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Micurx Pharmaceutical Co., Ltd. Class A